Search research articles
Contact Us
Filters
Showing results (91-100 of 450) with videos related to
Page
of 45
Sort By:
Current Opinion in Cell Biology
|
April 1, 2014
Tuning up the right signal: chemical and genetic approaches to study GPCR functions
Patrick M Giguere, Wesley K Kroeze, Bryan L Roth
Drug Discovery Today
|
November 5, 2013
DREADDs: novel tools for drug discovery and development
Hyeong-Min Lee, Patrick M Giguere, Bryan L Roth
CNS Drug Reviews
|
December 14, 2004
Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology
Marilyn A Davies, Douglas J Sheffler, Bryan L Roth
Neuropharmacology
|
July 22, 2008
Insights into the regulation of 5-HT2A serotonin receptors by scaffolding proteins and kinases
John A Allen, Prem N Yadav, Bryan L Roth
Journal of Neurochemistry
|
November 19, 2021
Molecular insights into psychedelic drug action
Samuel T Slocum, Jeffrey F DiBerto, Bryan L Roth
Cell Reports
|
August 17, 2022
Molecular insights into the regulation of constitutive activity by RNA editing of 5HT<sub>2C</sub> serotonin receptors
Ryan H Gumpper, Jonathan F Fay, Bryan L Roth
Journal of Psychopharmacology (Oxford, England)
|
December 3, 2016
Psilocybin for depression and anxiety associated with life-threatening illnesses
John D McCorvy, Reid Hj Olsen, Bryan L Roth
Bioorganic & Medicinal Chemistry Letters
|
January 24, 2007
Further studies on the binding of N1-substituted tryptamines at h5-HT6 receptors
Abner Nyandege, Renata Kolanos, Bryan L Roth, et al.
Bioinformatics (Oxford, England)
|
December 31, 2013
HTS navigator: freely accessible cheminformatics software for analyzing high-throughput screening data
Denis Fourches, Maria F Sassano, Bryan L Roth, et al.
Pharmacological Reviews
|
September 26, 2019
Harnessing Ion-Binding Sites for GPCR Pharmacology
Barbara Zarzycka, Saheem A Zaidi, Bryan L Roth, et al.
Page
of 45
Search research articles
Search
Showing results (91-100 of 450) with videos related to
Sort By:
Page
of 45
Current Opinion in Cell Biology
|
April 1, 2014
Tuning up the right signal: chemical and genetic approaches to study GPCR functions
Patrick M Giguere, Wesley K Kroeze, Bryan L Roth
Drug Discovery Today
|
November 5, 2013
DREADDs: novel tools for drug discovery and development
Hyeong-Min Lee, Patrick M Giguere, Bryan L Roth
CNS Drug Reviews
|
December 14, 2004
Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology
Marilyn A Davies, Douglas J Sheffler, Bryan L Roth
Neuropharmacology
|
July 22, 2008
Insights into the regulation of 5-HT2A serotonin receptors by scaffolding proteins and kinases
John A Allen, Prem N Yadav, Bryan L Roth
Journal of Neurochemistry
|
November 19, 2021
Molecular insights into psychedelic drug action
Samuel T Slocum, Jeffrey F DiBerto, Bryan L Roth
Cell Reports
|
August 17, 2022
Molecular insights into the regulation of constitutive activity by RNA editing of 5HT<sub>2C</sub> serotonin receptors
Ryan H Gumpper, Jonathan F Fay, Bryan L Roth
Journal of Psychopharmacology (Oxford, England)
|
December 3, 2016
Psilocybin for depression and anxiety associated with life-threatening illnesses
John D McCorvy, Reid Hj Olsen, Bryan L Roth
Bioorganic & Medicinal Chemistry Letters
|
January 24, 2007
Further studies on the binding of N1-substituted tryptamines at h5-HT6 receptors
Abner Nyandege, Renata Kolanos, Bryan L Roth, et al.
Bioinformatics (Oxford, England)
|
December 31, 2013
HTS navigator: freely accessible cheminformatics software for analyzing high-throughput screening data
Denis Fourches, Maria F Sassano, Bryan L Roth, et al.
Pharmacological Reviews
|
September 26, 2019
Harnessing Ion-Binding Sites for GPCR Pharmacology
Barbara Zarzycka, Saheem A Zaidi, Bryan L Roth, et al.
Page
of 45